Zydus Lifesciences
Latest news, explainers and analysis on Zydus Lifesciences. Tracking 3 stories on Arth Vani.
Connected in the graph
Latest on Zydus Lifesciences
Zydus Lifesciences Expands US Footprint with ₹1,400 Crore Assertio Acquisition
Indian pharmaceutical major Zydus Lifesciences has completed the acquisition of US-based Assertio Holdings for approximately ₹1,400 crore ($166.4 million). The move aims to strengthen Zydus's portfolio in high-value specialty drugs and cancer support therapies.
Market Momentum: Zydus Lifesciences, Federal Bank Hit New 52-Week Highs
Four major stocks from the BSE 200 index reached their highest price levels in a year as the Sensex ended in the green. Zydus Lifesciences, Federal Bank, Adani Ports, and Apollo Hospitals are showing strong momentum, gaining up to 17% in just one month.
Last Call for Zydus Lifesciences, Dhanuka Agritech Buybacks: Deadline Ends Today
Retail investors have until the end of today to tender their shares in three major buyback offers worth over ₹1,185 crore. Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems are offering to buy back shares at a premium through the tender route.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.